Investors

Why invest in Aereus Technologies?

EconomicsAereus Shield meets an urgent need for an antimicrobial touch surface that has the potential to improve infection control. In the USA alone 4.5% of hospitalized patients, or roughly 2 million people, develop hospital-acquired infections (HAIs), resulting in 100,000 deaths and a $35 – $45 billion hike in healthcare costs.

Its innovative technology is unmatched by its competitors. Aereus Shield’s superior benefits include: better efficacy, lower costs for manufacturers, longer product life and an attractive nickel finish. Composed of natural minerals, the Shield is 100% eco-friendly, non-toxic and recyclable. By corrupting bacterial cells on contact, Aereus Shield inhibits bacterial resistance and mutation.

In addition, the copper coating has impressively high market potential, allowing it to respond to the growing demand for antimicrobial solutions in healthcare environments.

A study conducted by Arrowhead Publishers indicates that the global anti-infective market was valued at $66.5 billion in 2007, and the global antibacterial marketplace reached $45 billion in 2012. Aereus Technologies competes in a rapidly-expanding and relatively untapped sub-market: antimicrobial coatings.

According to Transparency Market Research, the global antimicrobial coatings market was worth US$1.6 billion in 2012 and is estimated to reach US$3.3 billion in 2018. In the healthcare market alone, the market demand for antimicrobial coatings is expected to grow at a compound annual growth rate (CAGR) of 12.6% between 2012 and 2018.

Product verticals are virtually endless, allowing Aereus to tap into a wide variety of industries across the world.

The company’s strategic business model is designed to enhance share value by tactfully allocating capital and minimizing operational costs.